Health Security is a $10 billion market
Medical countermeasures for biological, chemical, radiological and nuclear attacks, as well as vaccines, therapeutics and diagnostics for emerging infectious diseases
We are a public, commercial-stage pharmaceutical company focused on providing solutions for unmet needs in health security.
We have proven relationships with key health security constituencies in the U.S. government.
TPOXX would play a critical role in responding to a smallpox bioterror attack.
Jun 18, 2019
Jun 11, 2019
Jun 3, 2019
May 20, 2019
Feb 21, 2019
Nov 1, 2018